Navidea Biopharmaceuticals, Inc. Gains 32.78%

Wed, Aug 16, 2023 at 07:32 PM
Navidea Biopharmaceuticals, Inc. Gains 32.78%

Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT) rocketted at $0.1, representing a gain of 32.8%. On Wed, Aug 16, 2023, NAVB:NYSEMKT hit a New 2-Week High of $0.1. The stock appeared on our News Catalysts scanner on Tue, Aug 01, 2023 at 08:35 AM in the 'INVESTOR UPDATE' category. From Wed, Aug 02, 2023, the stock recorded 20.00% Up Days and 18.18% Green Days

The stock spiked on Fri, Jun 16, 2023 at $0.17 with a volume of 126M+.

About Navidea Biopharmaceuticals, Inc. (NAVB:NYSEMKT)

Navidea Biopharmaceuticals Inc is a biotechnology company engaged in precision medicine. Its products are designed to assist in the identification of undetected diseases and develop treatment for cancer, autoimmune conditions, and inflammatory diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.